A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: Investigation of the current protocol through theoretical modelling results

Bulletin of Mathematical Biology

Volumn 67, Issue 1, 2005, Pages 79-99

  Ribba, B ^a   Marron, K ^a   Agur, Z ^a   Alarcon T ^b   Maini, P K ^b  

^a Institute for Medical Biomathematics Isarel   (Israel)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ARTICLE; BLOOD FLOW; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER SIMULATION; DRUG EFFECT; HUMAN; KINETICS; NONHODGKIN LYMPHOMA; THEORETICAL MODEL; TIME; TREATMENT OUTCOME;

CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER SIMULATION; DOXORUBICIN; HUMANS; KINETICS; LYMPHOMA, HIGH-GRADE; LYMPHOMA, INTERMEDIATE-GRADE; LYMPHOMA, LOW-GRADE; LYMPHOMA, NON-HODGKIN; MODELS, THEORETICAL; REGIONAL BLOOD FLOW; TIME FACTORS; TREATMENT OUTCOME;

EID: 13244297069     PISSN: 00928240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bulm.2004.06.007     Document Type: Article

References (43)

1. Z. Agur Randomness, synchrony and population persistence J. Theor. Biol. 112 1985 677 693
2. Z. Agur, R. Arnon, and B. Schechter Reduction of cytotoxicity to normal tissues by new regimens of phase-specific drugs Math. Biosci. 92 1988 1 15
3. T. Alarcón, H.M. Byrne, and P.K. Maini A cellular automaton model for tumor growth in inhomogeneous environment J. Theor. Biol. 225 2003 257 274
4. Alarcón, T., Byrne, H.M., Maini, P.K., Design principle of vascular beds: effects of blood rheology (in preparation)
5. B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, and J.D. Watson Molecular Biology of the Cell 1994 Garland Publishing New York and London
6. S.A. Al-Ismail, J.A. Whittaker, and J. Gough Combination chemotherapy including Epirubicin for the management of non-Hodgkin's lymphoma Eur. J. Cancer Clin. Oncol. 23 1987 1379 1384
7. A.R.A. Anderson, and M.A.J. Chaplain Continuous and discrete mathematical models of tumour-induced angiogenesis Bull. Math. Biol. 60 1998 857 899
8. A.R.A. Anderson, M.A.J. Chaplain, E.L. Newman, R.J.C. Steele, and A.M. Thompson Mathematical modelling of tumor invasion and metastasis J. Theor. Med. 2 2000 129 154
9. L. Arakelyan, V. Vainstein, and Z. Agur A computer algorithm describing the process of vessel formation and maturation and its use for predicting the effects of anti-angiogenic and multi-maturation therapy on vascular tumor growth Angiogenesis 5 2002 203 214
10. S.C. Barranco Cellular and molecular effects of Adriamycin on dividing and nondividing cells Pharmacol. Ther. 24 1984 303 319
11. R.C. Bast, D.W. Kufe, R.E. Pollock, R.R. Weichselbaum, and J.F. Holland Cancer Medicine 2000 BC Decker Inc Canada
12. L.E. Benjamin, D. Golijanin, A. Itin, D. Pode, and E. Keshet Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal J. Clin. Invest. 103 1999 157 158
13. M.V. Blagosklonny, and A.B. Pardee The restriction point of the cell cycle Cell Cycle 1 2002 103 110
14. C.C. Boring, T.S. Squires, T. Tong, and S. Montgomery Cancer statistics, 1994 C.A. Cancer J. Clin. 44 1994 7 26
15. P.P. Brons, J.M. Raemaekers, M.J. Bogman, P.E. van Erp, J.B. Boezeman, A.H. Pennings, H.M Wessels, and C. Haanen Cell cycle kinetics in malignant lymphoma studied with in vivo Iodeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry Blood 1 80 1992 2336 2343
16. J.J. Casciari, S.V. Sotirchos, and R.M. Sutherland Glucose diffusivity in multicellular tumor spheroids Cancer Res. 48 1998 3905 3909
17. L. Cojocaru, and Z. Agur A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs Math. Biosci. 109 1992 85 97
18. B. Couderc, J.P. Dujols, F. Mokhtari, J.L. Norkowski, J.C. Slawinski, and D. Schlaifer The management of adult aggressive non-Hodgkin's lymphomas Crit. Rev. Oncol. Hematol. 35 2000 33 48
19. C. Crone, and D.G. Levitt Handbook of Physiology: A Critical, Comprehensive Presentation of Physiological Knowledge and Concepts 1984 American Physiological Society Bethesda, ML
20. A. Deutsch, and S. Dormann Modeling of avascular tumor growth with a hybrid cellular automaton In Silico Biol. 2 2002 1 14
21. G Enden, and A.S. Popel A numerical study of plasma skimming in small vascular bifurcations J. Biomech. Eng. 116 1994 79 88
22. M. Erlanson, J. Lindth, B. Zackrisson, G. Landberg, and G. Roos Cell kinetic analysis of non-Hodgkin's lymphomas using in vivo Iodeoxyuridine incorporation and flow cytometry Hematol. Oncol. 13 1995 207 217
23. W. Hackbusch Multigrid Methods and Applications 1985 Springer Berlin
24. J.G. Hardman, L.E. Limbird, and A.G. Gilman The Pharmacological Basis of Therapeutics 2001 McGraw-Hill Companies
25. H. Honda, and K. Yoshizato Formation of branching pattern of blood vessels in the wall of the avian yolk sac studied by computer simulation Dev. Growth Differ. 39 1997 581 589
26. R.K. Jain Delivery of molecular and cellular medicine to solid tumours Adv. Drug. Deliv. Rev. 46 2001 146 168
27. M.A. Konerding, E. Fait, and A. Gaumann 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon Br. J. Cancer. 84 2001 1354 1362
28. T.T. Kwok, and P.R. Twentyman The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroid Br. J. Cancer. 51 1985 211 218
29. J. Lankelma, R.F. Luque, H. Dekker, W. Schinkel, and H. Pinedo A mathematical model of drug transport in human breast cancer Microvasc. Res. 59 2000 149 161
30. M. Lapela, S. Leskinen, H.R. Minn, P. Lindholm, P.J. Klemi, K.O. Soderstrom, J. Bergman, M. Haaparanta, U. Ruotsalainen, and O. Solin Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-19-fluorodeoxyglucose Blood 1 86 1995 3522 3527
31. E. Lepage, C. Gisselbrecht, C. Haioun, C. Sebban, H. Tilly, A. Bosly, P. Morel, R. Herbrecht, F. Reyes, and B. Coiffier Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte) Ann. Oncol. 4 1993 651 656
32. L.A. Liotta, G.M. Saidel, and J. Kleinerman Diffusion model of tumor vascularization and growth Bull. Math. Biol. 39 1977 117 128
33. S.F. McCormick Multigrid Methods 1987 SIAM Philadelphia
34. S.R. McDougall, A.R.A. Anderson, M.A.J. Chaplain, and J.A. Sherratt Mathematical modelling of flow through vascular networks: Implications for tumour-induced angiogenesis and chemotherapy strategies Bull. Math. Biol. 64 2002 673 702
35. K. Nagai, K. Nagasawa, Y. Sadzuka, M. Tsujimoto, K. Takara, N. Ohnishi, T. Yokoyama, and S. Fujimoto Relationships between the in vitro cytotoxicity and transport characteristics of Pirarubicin and Doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells Cancer Chemother. Pharmacol. 49 2002 244 250
36. M.E. Orme, and M.A.J. Chaplain A mathematical model of vascular tumour growth and invasion Math. Comput. Modelling 23 1996 43 60
37. A.A. Patel, E.T. Gawlinski, S.K. Lemieux, and R.A. Gatenby A cellular automaton model of early tumor growth and invasion J. Theor. Biol. 7 213 2001 315 331
38. A.R. Pries, T.W. Secomb, and P. Gaehtgens Structural adaptation and stability of microvascular networks: theory and simulations Am. J. Physiol. 275 1998 H349 H360
39. A.R. Pries, T.W. Secomb, T. Gessner, M.B. Sperandio, J.F. Gross, and P. Gaehtgens Resistance to blood flow in microvessels in vivo Circ. Res. 75 1994 904 915
40. T. Stokke, H. Holte, L. Smedshammer, E.B. Smeland, O. Kaalhus, and H.B. Steen Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas Br. J. Cancer 77 1998 1832 1838
41. Willemse, F., Nap, M., de Bruijn. H.W.A., Hollema, H., Morphological parameters of vasculature in tumor marker biodynamics. Anal. Quant. Histol. (in press)
42. J.D Wilson, and D.W. Foster Williams Textbook of Endocrinology 1992 W.B. Saunders Company
43. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash Vascular specific growth factors and blood vessel formation Nature 407 2000 242 248